Zaltrap
Active Ingredient(s): Ziv afliberceptFDA Approved: * August 3, 2012
Pharm Company: * SANOFI AVENTIS US
Category: Cancer
Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and the European Union.[2][3] It is an inhibitor of vascular endothelial growth factor (VEGF).[4][5] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Mechanism of action ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Popular Topics
Zaltrap - help
My husband has just started on Zaltrap. Is there anyone else that is on this drug? (So very little information out there...
Zaltrap
Hi Does anyone know the CPT code for Zaltrap?...